Skip to main content
An official website of the United States government

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Evans Williams, Felicia, M.B.A.
felicia.evanslong@nih.gov
240-276-5076
5E636 Program Analyst | Cancer Biomarkers
Fu, Sidney, M.D.
sidney.fu@nih.gov
240-276-6669
5E134 Program Officer | Cancer Biomarkers
Hodges, Nicholas, Ph.D.
nick.hodges@nih.gov
240-276-7844
5E616 Program Officer | Cancer Biomarkers
Kohaar, Indu, Ph.D., M.Phil., M.Sc.
indu.kohaar@nih.gov
240-620-0875
5E612 Program Officer | Cancer Biomarkers
Krueger, Karl, Ph.D. [V]
karl.krueger@nih.gov
Volunteer | Cancer Biomarkers
Marquez, Guillermo, Ph.D.
guillermo.marquez@nih.gov
240-276-7035
5E132 Program Officer | Cancer Biomarkers
Orr, Susan
susan.orr@nih.gov
240-276-5001
5E626 Program Support Assistant | Cancer Biomarkers
Patriotis, Christos, Ph.D., M.Sc.
christos.patriotis@nih.gov
240-276-7134
5E614 Deputy Chief | Cancer Biomarkers
Petruzzelli, Angie
angie.petruzzelli@nih.gov
240-276-5076
5E624 Program Support Assistant | Cancer Biomarkers
Srivastava, Sudhir, Ph.D., M.P.H.
sudhir.srivastava@nih.gov
240-276-7028
5E136 Chief | Cancer Biomarkers
Villanueva, Juan Miguel
juan.villanueva@nih.gov
5E630 Program Analyst | Cancer Biomarkers
Wang, Wendy, Ph.D., M.Sc.
wendy.wang@nih.gov
240-276-7117
5E566 Program Officer | Cancer Biomarkers
Young, Matthew, Ph.D.
matthew.young@nih.gov
240-276-5846
5E610 Program Officer | Cancer Biomarkers

Grants

PI Name PI Organization Sort descending Title Grant Number Program Official
Stachler, Matthew D

University Of California, San Francisco
United States

Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus 5R37CA269649-04 Matthew Young, Ph.D.
Lampe, Paul D.

Fred Hutchinson Cancer Center
United States

Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer 5R01CA281801-03 Guillermo Marquez, Ph.D.
Pozdeyev, Nikita

University Of Colorado Denver
United States

Genetic architecture of thyroid cancer and its clinical utility 5R21CA282380-02 Wendy Wang, Ph.D., M.Sc.
Wang, Thomas D

University Of Michigan At Ann Arbor
United States

Early detection of colorectal cancer in the traditional and serrated pathways 5R01CA249851-05 Guillermo Marquez, Ph.D.
Majumder, Shounak

Mayo Clinic Rochester
United States

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer 5U01CA210138-09 Matthew Young, Ph.D.
Godwin, Andrew K.

University Of Kansas Medical Center
United States

Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem 5R01CA260132-05 Matthew Young, Ph.D.
Rotemberg, Veronica Miriam

Sloan-Kettering Inst Can Research
United States

M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection 5U24CA264369-04 Guillermo Marquez, Ph.D.
Zhang, Zhen

Johns Hopkins University
United States

A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach 5U2CCA271891-04 Christos Patriotis, Ph.D., M.Sc.
Lin, Jia-Ren

Harvard Medical School
United States

Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images 5R50CA274277-04 Guillermo Marquez, Ph.D.
Paulson, Thomas G

Fred Hutchinson Cancer Center
United States

The microbiome ecosystem of Barrett's esophagus and progression to cancer 5R21CA259687-02 Matthew Young, Ph.D.
Sukumar, Saraswati

Johns Hopkins University
United States

Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership 3R01CA278816-03S1 Matthew Young, Ph.D.
Taouli, Bachir

Icahn School Of Medicine At Mount Sinai
United States

Liquid biopsy and radiomics for liver cancer surveillance 4U01CA283931-03 Sidney Fu, M.D.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women 5R01CA260628-05 Christos Patriotis, Ph.D., M.Sc.
Bettegowda, Chetan

Johns Hopkins University
United States

Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid 5R37CA230400-07 Sidney Fu, M.D.
Feng, Ziding

Fred Hutchinson Cancer Center
United States

Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC) 5U24CA230144-09 Guillermo Marquez, Ph.D.